Phenotyping provides potential for a personalized approach in patients with chronic obstructive pulmonary disease (COPD)
作者：
DOI: 10.1007/S40267-015-0183-3
关键词:
摘要: Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disorder, with clinical response to the various available treatment options differing according characteristics. At least three different COPD phenotypes, each providing unique prognostic and therapeutic characteristics, have been identified in patients this offering potential for more targeted therapy.
springer.com
sci-hub.se 参考文章(22)
O. A. Minai, Z. Mosenifar, J. A. Falk, Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the American Thoracic Society. ,vol. 5, pp. 506- 512 ,(2008) , 10.1513/PATS.200707-096ET
John R. Hurst, Jørgen Vestbo, Antonio Anzueto, Nicholas Locantore, Hana Müllerova, Ruth Tal-Singer, Bruce Miller, David A. Lomas, Alvar Agusti, William MacNee, Peter Calverley, Stephen Rennard, Emiel F.M. Wouters, Jadwiga A. Wedzicha, Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease The New England Journal of Medicine. ,vol. 363, pp. 1128- 1138 ,(2010) , 10.1056/NEJMOA0909883
Andriana I. Papaioannou, Argyro Mazioti, Theodoros Kiropoulos, Irini Tsilioni, Angela Koutsokera, Kalliopi Tanou, Dimitrios J. Nikoulis, Panagiotis Georgoulias, Epameinondas Zakynthinos, Konstantinos I. Gourgoulianis, Konstantinos Kostikas, Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respiratory Medicine. ,vol. 104, pp. 275- 282 ,(2010) , 10.1016/J.RMED.2009.09.016
Keisaku Fujimoto, Komatsu, Keisaku Fujimoto, Masayuki Hanaoka, Keishi Kubo, Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. International Journal of Chronic Obstructive Pulmonary Disease. ,vol. 7, pp. 283- 289 ,(2012) , 10.2147/COPD.S30651
Andrea Segreti, Emanuele Stirpe, Paola Rogliani, Mario Cazzola, Defining Phenotypes in COPD: An Aid to Personalized Healthcare Molecular Diagnosis & Therapy. ,vol. 18, pp. 381- 388 ,(2014) , 10.1007/S40291-014-0100-9
Mikell Paige, Marie D. Burdick, Suhyon Kim, Junrui Xu, Jae K. Lee, Y. Michael Shim, Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype Biochemical and Biophysical Research Communications. ,vol. 413, pp. 588- 593 ,(2011) , 10.1016/J.BBRC.2011.09.006
N. Fens, M. P. van der Schee, P. Brinkman, P. J. Sterk, Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions. Clinical & Experimental Allergy. ,vol. 43, pp. 705- 715 ,(2013) , 10.1111/CEA.12052
Peter M A CalverleKlaus F Rabe, Udo-Michael Goehring, Søren Kristiansen, Leonardo M Fabbri, Fernando J Martinez, M2-124 and M2-125 study groups, None, Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials The Lancet. ,vol. 374, pp. 685- 694 ,(2009) , 10.1016/S0140-6736(09)61255-1
P Boschetto, S Quintavalle, E Zeni, S Leprotti, A Potena, L Ballerin, A Papi, G Palladini, M Luisetti, L Annovazzi, P Iadarola, E De Rosa, L M Fabbri, C E Mapp, Association between markers of emphysema and more severe chronic obstructive pulmonary disease Thorax. ,vol. 61, pp. 1037- 1042 ,(2006) , 10.1136/THX.2006.058321
Yoshiaki Kitaguchi, Keisaku Fujimoto, Keishi Kubo, Takayuki Honda, Characteristics of COPD phenotypes classified according to the findings of HRCT Respiratory Medicine. ,vol. 100, pp. 1742- 1752 ,(2006) , 10.1016/J.RMED.2006.02.003